Literature DB >> 17613220

The genetic predisposition to and histogenesis of neurofibromas and neurofibrosarcoma in neurofibromatosis type 1.

Vincent M Riccardi1.   

Abstract

The author addresses the issue of neurofibroma classification and implications for treatment. He emphasizes the importance of understanding that not all neurofibromas are the same and that the key differences between the types of neurofibromas involve which portions of the nerve sheath contribute to the distinctive behavior of the different types of lesions. Endoneurial neurofibromas derive from cellular elements ordinarily restricted to the endoneurium. Perineurial neurofibromas arise within individual fascicles of a nerve and are largely confined thereby, precluding a breach of the epineurium. Epineurial neurofibromas are contained only by the epineurium, and ultimately that portion of the nerve sheath is breached by these lesions. Whether the perineurium is present or breached becomes the key element for exploiting this approach to neurofibroma origins, behaviors, and treatment, surgical and medical. With respect to surgical treatment, perineurial neurofibromas will have clean planes of dissection about the involved nerve. In contrast, endoneurial and epineurial neurofibromas infiltrate adjacent tissues, leading to surgical challenges. With respect to pharmaceutical approaches, the integrity of the perineurium is likely to prove critical: a specific function of the perineurium is to serve as a barrier to various materials, microbiological or chemical. Thus, drugs that might be effective when the perineurium is absent or rent may be less effective (or not effective at all) if the perineurium is intact, as is expected in cases of perineurial neurofibromas.

Entities:  

Mesh:

Year:  2007        PMID: 17613220     DOI: 10.3171/foc.2007.22.6.4

Source DB:  PubMed          Journal:  Neurosurg Focus        ISSN: 1092-0684            Impact factor:   4.047


  12 in total

1.  Could an osteoinductor result in degeneration of a neurofibroma in NF1?

Authors:  Jean-Paul Steib; Steib Jean-Paul; Julia Bouchaïb; Bouchaïb Julia; Axel Walter; Walter Axel; Sébastien Schuller; Schuller Sébastien; Yann Philippe Charles; Charles Philippe
Journal:  Eur Spine J       Date:  2010-05-07       Impact factor: 3.134

Review 2.  The pathoetiology of neurofibromatosis 1.

Authors:  Eeva-Mari Jouhilahti; Sirkku Peltonen; Anthony M Heape; Juha Peltonen
Journal:  Am J Pathol       Date:  2011-03-31       Impact factor: 4.307

3.  Oral soft tissue alterations in patients with neurofibromatosis.

Authors:  Eeva-Mari Jouhilahti; Vivian Visnapuu; Tero Soukka; Heikki Aho; Sirkku Peltonen; Risto-Pekka Happonen; Juha Peltonen
Journal:  Clin Oral Investig       Date:  2011-02-08       Impact factor: 3.573

4.  Expression analysis of genes lying in the NF1 microdeletion interval points to four candidate modifiers for neurofibroma formation.

Authors:  B Bartelt-Kirbach; M Wuepping; M Dodrimont-Lattke; D Kaufmann
Journal:  Neurogenetics       Date:  2008-10-11       Impact factor: 2.660

5.  Transient brown adipocyte-like cells derive from peripheral nerve progenitors in response to bone morphogenetic protein 2.

Authors:  Elizabeth A Salisbury; Zawaunyka W Lazard; Eroboghene E Ubogu; Alan R Davis; Elizabeth A Olmsted-Davis
Journal:  Stem Cells Transl Med       Date:  2012-11-26       Impact factor: 6.940

6.  Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1.

Authors:  Victor-F Mautner; Florence A Asuagbor; Eva Dombi; Carsten Fünsterer; Lan Kluwe; Ralf Wenzel; Brigitte C Widemann; Jan M Friedman
Journal:  Neuro Oncol       Date:  2008-06-17       Impact factor: 12.300

7.  Receptor of ghrelin is expressed in cutaneous neurofibromas of individuals with neurofibromatosis 1.

Authors:  Rafaela E Rozza-de-Menezes; Nicolle C Gaglionone; Raquel M Andrade-Losso; Orlando H K Siqueira; Lilian M Almeida; Kamila da S Peruzini; Marco A C Guimarães-Filho; Carolina I Brum; Mauro Geller; Karin S Cunha
Journal:  Orphanet J Rare Dis       Date:  2017-12-20       Impact factor: 4.123

8.  Genotype-Phenotype Correlations in Neurofibromatosis and Their Potential Clinical Use.

Authors:  Chetan Bettegowda; Meena Upadhayaya; D Gareth Evans; AeRang Kim; Dimitrios Mathios; Clemens O Hanemann
Journal:  Neurology       Date:  2021-07-06       Impact factor: 11.800

9.  Brain Herniation in Neurofibromatosis with Dysplasia of Occipital Bone and Posterior Skull Base.

Authors:  Vithal Rangarajan; Amit Mahore; Manoj Patil; Prashant Sathe; Amol Kaswa; Sandeep Gore; Pralhad Dharurkar; Juhi Kawale
Journal:  Case Rep Neurol Med       Date:  2015-10-27

10.  Factors Within the Endoneurial Microenvironment Act to Suppress Tumorigenesis of MPNST.

Authors:  Jo Anne Stratton; Peggy Assinck; Sarthak Sinha; Ranjan Kumar; Aaron Moulson; Natalya Patrick; Eko Raharjo; Jennifer A Chan; Rajiv Midha; Wolfram Tetzlaff; Jeff Biernaskie
Journal:  Front Cell Neurosci       Date:  2018-10-11       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.